Paper - WANFANG MED ONLINE

You Position: Home > Paper

Neurotrophic factor-based pharmacological approaches in neurological disorders

( views:9, downloads:0 )

Author:: No author available

Journal Title:: Neural Regeneration Research

Issue:: 6

DOI:: No doi available

Key Word:: Alzheimer's disease;brain;brain-derived neurotrophic factor;glial cell-derived neurotrophic factor;nerve growth factor;neurotrophins;neurturin;Parkinson's disease;stroke;tropomyosin receptor kinase receptors

Abstract： Aging is a physiological event dependent on multiple pathways that are linked to lifespan and processes leading to cognitive decline.This process represents the major risk factor for aging-related diseases such as Alzheimer's disease,Parkinson's disease,and ischemic stroke.The incidence of all these pathologies increases exponentially with age.Research on aging biology has currently focused on elucidating molecular mechanisms leading to the development of those pathologies.Cognitive deficit and neurodegeneration,common features of aging-related pathologies,are related to the alteration of the activity and levels of neurotrophic factors,such as brain-derived neurotrophic factor,nerve growth factor,and glial cell-derived neurotrophic factor.For this reason,treatments that modulate neurotrophin levels have acquired a great deal of interest in preventing neurodegeneration and promoting neural regeneration in several neurological diseases.Those treatments include both the direct administration of neurotrophic factors and the induced expression with viral vectors,neurotrophins'binding with biomaterials or other molecules to increase their bioavailability but also cell-based therapies.Considering neurotrophins'crucial role in aging pathologies,here we discuss the involvement of several neurotrophic factors in the most common brain aging-related diseases and the most recent therapeutic approaches that provide direct and sustained neurotrophic support.

Reference

[1]Rick B Meeker,Kimberly S Williams.The p75 neurotrophin receptor: at the crossroad of neural repair and death[J].2015,(5).
[2]Ma Isabel Alonso,Angel Gato.Cerebrospinal fluid and neural stem cell niche control[J].2018,(9).
[3]Derek L. Choi-Lundberg,Qing Lin,Yung-Nien Chang,etc.Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy[J].1997,275(1).
[4]Underwood CK,Coulson EJ.The p75 neurotrophin receptor.[J].2008,40(9).
[5]Matti S. Airaksinen,Mart Saarma.The GDNF family: signalling, biological functions and therapeutic value[J].2002,3(5).
[6]Guo-Fang Chen,Ting-Hai XU,YAN Yan,etc.Amyloid beta: structure, biology and structure-based therapeutic development[J].2017,38(9).
[7]Paoletti F,Cattaneo A,Capsoni S.Towards non invasive nerve growth factor therapies for Alzheimer's disease.[J].2008,15(2).
[8]Fjord Larsen L,Johansen JL,Kusk P,etc.Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct.[J].2005,195(1).
[9]Clarkson, Andrew N.,Parker, Kim,Nilsson, Michael,etc.Combined ampakine and BDNF treatments enhance poststroke functional recovery in aged mice via AKT-CREB signaling[J].2015,35(8).
[10]Berretta,A.,Tzeng,Y.-C.,Clarkson,A.N..Post-stroke recovery: The role of activity-dependent release of brain-derived neurotrophic factor[J].2014,14(11).
[11]Yazan, Haddad,Vojtěch, Adam,Zbyněk, Heger.Trk Receptors and Neurotrophin Cross-Interactions: New Perspectives Toward Manipulating Therapeutic Side-Effects.[J].2017,10(Spec ).
[12]Mart Saarma,Hannu Sariola.Other neurotrophic factors: Glial cell line‐derived neurotrophic factor (GDNF)[J].1999,45(4‐5).
[13]Wei,Liu,Xiaohui,Wang,Margaret,O'Connor,etc.Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities.[J].2020,2020.
[14]Trupp M,Ibanez CF,Belluardo N,etc.Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS.[J].1997,17(10).
[15]Gustavo Paratcha,Fernanda Ledda,Carlos F. Ibáñez.The Neural Cell Adhesion Molecule NCAM Is an Alternative Signaling Receptor for GDNF Family Ligands[J].2003,113(7).
[16]Francardo,V.,Bez,F.,Wieloch,T.,etc.Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism[J].2014,137(7).
[17]Bickford PC,Baquet ZC,Jones KR.Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.[J].2005,25(26).
[18]Sariola H.,Saarma M..Novel functions and signalling pathways for GDNF[J].2003,116(19).
[19]Gomez Diaz R,Pascual A,Hidalgo Figueroa M,etc.GDNF and protection of adult central catecholaminergic neurons.[J].2011,46(3).
[20]Annett, Geralyn,Anderson, Johnathon D.,Fink, Kyle D.,etc.Engineered BDNF producing cells as a potential treatment for neurologic disease[J].2016,16(8).
[21]Cook, Douglas J.,Nguyen, Cynthia,Chun, Hyun N.,etc.Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke[J].2017,37(3).
[22].Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.[J].2019,20(2).
[23]Nagahara, A. H.,Bernot, T.,Moseanko, R.,etc.Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery[J].2009,215(1).
[24]Thornhill SI,Schambach A,Howe SJ,etc.Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency.[J].2008,16(3).
[25]von Bohlen und Halbach Oliver,von Bohlen und Halbach Viola.BDNF effects on dendritic spine morphology and hippocampal function[J].2018,373(3).
[26]Ana Paula,De Vincenti,Antonella S,Ríos,Gustavo,Paratcha,etc.Mechanisms That Modulate and Diversify BDNF Functions: Implications for Hippocampal Synaptic Plasticity.[J].2019,13.
[27]Zuccato Chiara,Cattaneo Elena.Brain-derived neurotrophic factor in neurodegenerative diseases[J].2009,5(6).
[28]S H, Appel.A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease.[J].1981,10(6).
[29]Capsoni S,Brandi R,Arisi I,etc.A Dual Mechanism Linking NGF/proNGF Imbalance and Early Inflammation to Alzheimer's Disease Neurodegeneration in the AD11 Anti-NGF Mouse Model.[J].2011,10(5).
[30]Zhang Zhe,Sun Grace Y.,Ding Shinghua.Glial Cell Line-Derived Neurotrophic Factor and Focal Ischemic Stroke[J].2021,46(10).
[31]Kawano Y,Date I,Honmou O,etc.BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model.[J].2004,9(2).
[32]L.G. Isaacson,B.N. Saffran,K.A. Crutcher.Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels[J].1990,11(1).
[33]Tirasa, P..The nerve growth factor administrated as eye drops activates mature and precursor cells in subventricular zone of adult rats[J].2011,149(2).
[34]Samuel E. Marsh,Mathew Blurton-Jones.Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support[J].2017,106.
[35]Juri C,Wyneken U,Baes M,etc.Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.[J].2010,16(11).
[36]Runeberg-Roos, Pia,Piccinini, Elisa,Penttinen, Anna-Maija,etc.Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease[J].2016,96.
[37]Junying Cai,Fuzhou Hua,Linhui Yuan,etc.Potential Therapeutic Effects of Neurotrophins for Acute and Chronic Neurological Diseases[J].2014,2014(14).
[38]Eyileten, Ceren,Sharif, Lucia,Wicik, Zofia,etc.The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke[J].2021,58(1).
[39]Zhang, Xuemei,Zhou, Yinglian,Li, Hulun,etc.Intravenous administration of DPSCs and BDNF improves neurological performance in rats with focal cerebral ischemia[J].2018,41(6).
[40]Michalski B,Coughlin MD,Xu B,etc.The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in alzheimer's disease.[J].2001,18(2).
[41]Michael S.?Rafii,Mark H.?Tuszynski,Ronald G.?Thomas,etc.Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer DiseaseA Randomized Clinical Trial[J].2018,75(7).
[42]Christine J. Fontaine,Carina P. Lottenberg,Juan Trivi?o-Paredes,etc.Revisiting the flip side: Long-term depression of synaptic efficacy in the hippocampus[J].2017,80.
[43]Simon Allard,Marie L. Jacobs,Sonia Do Carmo,etc.Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons[J].2018,67.
[44]Kim HJ,Lee JH,Kim SH.Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis.[J].2010,27(1).
[45]Kocahan, Sayad,Do?an, Zumrut..Mechanisms of Alzheimer's Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors.[J].2017,15(1).
[46]Kollmar R,Berger C,Kiessling M,etc.Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia.[J].2004,35(4).
[47]Bankiewicz KS,Johnston L,Hadaczek P,etc.Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain.[J].2010,58(7).
[48]Barthels, Derek,Das, Hiranmoy.Current advances in ischemic stroke research and therapies[J].2020,1866(4).
[49]Hong, Chen,Georgiana Zong Xin, Yang,Hoheteberhan, Getachew,etc.Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor.[J].2016.
[50]Nagatsu, T.,Sawada, M..Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects[J].2007,72(1).
[51]Deardorff, William James,Feen, Eliahu,Grossberg, George T..The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease[J].2015,32(7).
[52]S. Korsching,G. Auburger,R. Heumann,etc.Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation.[J].1985,4(6).
[53]Xiaoqiang,Li,Fangming,Li,Li,Ling,etc.Nerve growth factor%PI3K/Akt signaling pathway%angiogenesis%ischemic stroke[J].2018,10(11).
[54]Kowiański Przemysław,Lietzau Grażyna,Czuba Ewelina,etc.BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity[J].2017,38(3).
[55]Rosenblad C,Kirik D,Bjorklund A.Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.[J].2000,161(2).
[56]Chmielarz Piotr,Saarma Mart.Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies[J].2020,72(5).
[57]Josh,Houlton,Nashat,Abumaria,Simon F R,Hinkley,etc.Therapeutic Potential of Neurotrophins for Repair After Brain Injury: A Helping Hand From Biomaterials.[J].2019,13.
[58]E J, Mufson,S Y, Ma,E J, Cochran,etc.Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.[J].2000,427(1).
[59]Yoshihiro, Konishi,Li-Bang, Yang,Ping, He,etc.Deficiency of GDNF Receptor GFRα1 in Alzheimer's Neurons Results in Neuronal Death.[J].2014,34(39).
[60]Vanessa,Castelli,Michele,d'Angelo,Francesca,Lombardi,etc.Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson's disease models.[J].2020,12(5).
[61]M, Seiler,M E, Schwab.Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.[J].1984,300(1).
[62]Baoji Xu,Emily G. Waterhouse.New insights into the role of brain-derived neurotrophic factor in synaptic plasticity[J].2009,42(2).
[63]Kim, Se Min,Patel, Madhumita,Patel, Rajkumar.PLGA Core -Shell Nano/Microparticle Delivery System for Biomedical Application[J].2021,13(20).
[64]Karlsson J,Emgard M,Schierle GS,etc.Improving the survival of grafted dopaminergic neurons: a review over current approaches.[J].2000,9(2).
[65]Jie Wang,Wei-Wei Hu,Zhi Jiang,etc.Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors[J].2020,(5).
[66]Scardigli,R.,Nisticò,R.,Tiveron,C.,etc.ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice[J].2013,20(8).
[67]Xinquan Wang,Robert H. Baloh,Jeffrey Milbrandt,etc.Structure of Artemin Complexed with Its Receptor GFRα3: Convergent Recognition of Glial Cell Line-Derived Neurotrophic Factors[J].2006,14(6).
[68]Nicoletta Berardi,Addys Ancheta Garcia,Roberta De Rosa,etc.Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice[J].2005,102(10).
[69]Ali Sajadi,Jean-Charles Bensadoun,Bernard L. Schneider,etc.Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease[J].2006,22(1).
[70]Fabbro S,Seeds NW.Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain.[J].2009,109(2).
[71]D.W. Howells,M.J. Porritt,J.Y.F. Wong,etc.Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra[J].2000,166(1).
[72]Di-Fausto V,Sposato V,Coassin M,etc.Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence.[J].2007,1127(1).
[73]Zhi-Hao Wang,Jie Xiang,Xia Liu,etc.Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer’s Disease[J].2019,28(3).
[74]Li Y,Luikart BW,Birnbaum S,etc.TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment.[J].2008,59(3).
[75].Plasma membrane localization of the GFL receptor components: a nexus for receptor crosstalk[J].2020,382(1).
[76]Baum C,Loew R,Galla M,etc.Improving Transcriptional Termination of Self-inactivating Gamma-retroviral and Lentiviral Vectors.[J].2007,15(6).
[77]Kuhn HG,Sommer C,Steigleder T,etc.Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis.[J].2007,38(7).
[78]Windle V,Corbett D,MacLellan CL,etc.Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats.[J].2009,40(4).
[79]Tuszynski, Mark H.,Yang, Jennifer H.,Barba, David,etc.Nerve Growth Factor Gene Therapy Activation of Neuronal Responses in Alzheimer Disease[J].2015,72(10).
[80]Hempstead B,Kermani P.Brain-derived neurotrophic factor: a newly described mediator of angiogenesis.[J].2007,17(4).
[81]Bahr M,Kilic E,Kilic U,etc.Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice.[J].2003,34(5).
[82]Pramanik, Subrata,Sulistio, Yanuar Alan,Heese, Klaus.Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy[J].2017,54(9).
[83]Jones AR,Shusta EV.Blood-brain barrier transport of therapeutics via receptor-mediation.[J].2007,24(9).
[84]Thal L,Potkin SG,Vahlsing HL,etc.A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.[J].2005,11(5).
[85]Atif, Fahim,Yousuf, Seema,Sayeed, Iqbal,etc.Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: The role of BDNF/TrkB/Erk1/2 signaling in neuroprotection[J].2013,67.
[86]Jiang, Chao,Zuo, Fangfang,Wang, Yuejuan,etc.Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged mice[J].2016,42.
[87]Doetsch F.The glial identity of neural stem cells.[J].2003,6(11).
[88]Altar CA,Mamounas LA,Tessarollo L,etc.BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain.[J].2000,20(2).
[89]Chu, Yaping,Bartus, Raymond T.,Manfredsson, Fredric P.,etc.Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease[J].2020,143(Pt.3).
[90]Hohsfield,L.A.,Geley,S.,Reindl,M.,etc.The generation of NGF-secreting primary rat monocytes: A comparison of different transfer methods[J].2013,391(1).
[91]Brown RE,Baker SA,Hagg T,etc.Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice.[J].2005,1039(1).
[92]Hayes, Michael T..Parkinson's Disease and Parkinsonism[J].2019,132(7).
[93]Ernfors P,Castren M,Sairanen M,etc.Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus.[J].2005,25(5).
[94]Kirik D,Georgievska B,Bjorklund A.Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer.[J].2002,177(2).
[95]Nawa H,Marvanova M,Wong G,etc.The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain.[J].2001,18(3).
[96]Mokhtari, Tahmineh,Akbari, Mohammad,Malek, Fatemeh,etc.Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region.[J].2017,25.
[97]Mroczko,B.,Groblewska,M.,Barcikowska,M..The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: A literature study[J].2013,37(2).
[98]Catts VS,Al-Menhali N,Burne TH,etc.The p75 neurotrophin receptor regulates hippocampal neurogenesis and related behaviours.[J].2008,28(5).
[99]Boado RJ,Pardridge WM,Zhang Y,etc.Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier[J].2007,97(6).
[100]Mar?al, Vilar,Helena, Mira.Regulation of Neurogenesis by Neurotrophins during Adulthood: Expected and Unexpected Roles.[J].2016.
[101]Che S,Mufson EJ,Ginsberg SD,etc.Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.[J].2006,97(2).
[102]Linda Nguyen,Bron P. Lucke-Wold,Shona Mookerjee,etc.Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection[J].2017,964.
[103]Rafii, M. S.,Baumann, T. L.,Bakay, R. A.,etc.A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease[J].2014,10(5).
[104]Liliane, Tenenbaum,Marie, Humbert-Claude.Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms.[J].2017,11(Spec ).
[105]Hisashi Ito,Shigeru Fukutake,Kazuaki Yamamoto,etc.Magnetic Resonance Imaging-guided Focused Ultrasound Thalamotomy for Parkinson's Disease[J].2018,57(7).
[106]Kobayashi R,Kobayashi T,Kokaia Z,etc.Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats.[J].2006,37(9).
[107]Caterina Rizzi,Alexia Tiberi,Michela Giustizieri,etc.NGF steers microglia toward a neuroprotective phenotype[J].2018,66(7).
[108]Stephen D, Skaper.Neurotrophic Factors: An Overview.[J].2018,1727(Spec ).
[109]Carrarini, Claudia,Russo, Mirella,Dono, Fedele,etc.A Stage-Based Approach to Therapy in Parkinson’s Disease[J].2019,9(8).
[110]Naoko Kaneko,Kazunobu Sawamoto.Go with the Flow: Cerebrospinal Fluid Flow Regulates Neural Stem Cell Proliferation[J].2018,22(6).
[111]Zagrebelsky Marta,Tacke Charlotte,Korte Martin.BDNF signaling during the lifetime of dendritic spines[J].2020,382(1).
[112]G,Kashyap,D,Bapat,D,Das,etc.Synapse loss and progress of Alzheimer's disease -A network model.[J].2019,9(1).
[113]Shohayeb Belal,Diab Mohamed,Ahmed Mazen,etc.Factors that influence adult neurogenesis as potential therapy[J].2018,7(1).
[114]Wang X,Lu XG,Sun M,etc.Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.[J].2005,1052(2).
[115]Hampel Harald,Mesulam M.-M.,Cuello A. C.,etc.Revisiting the Cholinergic Hypothesis in Alzheimer’s Disease: Emerging Evidence from Translational and Clinical Research[J].2018,6(1).
[116]Ewelina,Palasz,Wiktor,Niewiadomski,Anna,Gasiorowska,etc.Neuroplasticity and Neuroprotective Effect of Treadmill Training in the Chronic Mouse Model of Parkinson’s Disease.[J].2019,2019.
[117]M R, Hernandez,J D, Pena,J A, Selvidge,etc.Hydrostatic pressure stimulates synthesis of elastin in cultured optic nerve head astrocytes.[J].2000,32(2).
[118]Schambra HM,Lu B,Fritsch B,etc.Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning.[J].2010,66(2).
[119]J L, Ridet,N, Déglon,P, Aebischer.Gene transfer techniques for the delivery of GDNF in Parkinson's disease.[J].2000,231.
[120]Magdalena,Miranda,Juan Facundo,Morici,María Belén,Zanoni,etc.Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain.[J].2019,13.
[121]R, LEVI-MONTALCINI.The Nerve Growth Factor.[J].1964,118.
[122]Luigi, Aloe,Maria Luisa, Rocco,Patrizia, Bianchi,etc.Nerve growth factor: from the early discoveries to the potential clinical use.[J].2012,10.
[123]Cang,Chen,Michael J,Guderyon,Yang,Li,etc.Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson's Disease.[J].2020,17.
[124]Robert, Poser,Martin, Dokter,Viola, von Bohlen Und Halbach,etc.Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation and the population of postmitotic doublecortin positive cells in the dentate gyrus.[J].2015,9.
[125]Ingo Spitzbarth,Kathrin Becker,Armend Cana,etc.p75 Neurotrophin Receptor: A Double-Edged Sword in Pathology and Regeneration of the Central Nervous System[J].2018,55(6).
[126]Lucas,Morel,Olivia,Domingues,Jacques,Zimmer,etc.Revisiting the Role of Neurotrophic Factors in Inflammation.[J].2020,9(4).
[127]Isaac G, Onyango,Jeremy B, Tuttle,James P, Bennett.Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal death.[J].2005,20(1).
[128]Franciska Erd?,Dániel Farkas,ágnes Bajza,etc.Evaluation of intranasal delivery route of drug administration for brain targeting[J].2018,143.
[129]Blurton-Jones, M,Kitazawa, M,Martinez-Coria, H,etc.Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease[J].2009,106(32).
[130]Carmichael ST,Zhong S,Mueller R,etc.AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke.[J].2011,31(10).
[131]Dar D,Stall N,Taliaz D.Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis.[J].2010,15(1).
[132]Liu,X.,Obiany,O.,Chan,C.B.,etc.Biochemical and biophysical investigation of the brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone in the binding and activation of the trkb receptor[J].2014,289(40).
[133]Mark,Bothwell.Recent advances in understanding context-dependent mechanisms controlling neurotrophin signaling and function.[J].2019,8.
[134]Raheleh, Masoudi,Maria S, Ioannou,Michael D, Coughlin,etc.Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors.[J].2009,284(27).